(Q40308913)

English

Immunogenicity and protective efficacy of tuberculosis DNA vaccines combining mycolyl-transferase Ag85A and phosphate transport receptor PstS-3.

scientific article published on July 2006

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Immunogenicity and protective efficacy of tuberculosis DNA vaccines combining mycolyl-transferase Ag85A and phosphate transport receptor PstS-3. (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

0 references

8

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

4

object named as

Olivier Denis

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

author name string

Marta Romano

1

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Virginie Roupie

2

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Xiao M Wang

3

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Fabienne Jurion

5

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Pierre-Yves Adnet

6

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Rachid Laali

7

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

publication date

1 July 2006

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

118

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

321-332

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Immune responses to tuberculosis in developing countries: implications for new vaccines

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2006.02373.X

21 January 2018

How soon after infection with HIV does the risk of tuberculosis start to increase? A retrospective cohort study in South African gold miners

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2006.02373.X

21 January 2018

Tuberculosis vaccine development: recent progress

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2006.02373.X

21 January 2018

On the use of DNA vaccines for the prophylaxis of mycobacterial diseases

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2006.02373.X

21 January 2018

Crystal structure of the secreted form of antigen 85C reveals potential targets for mycobacterial drugs and vaccines

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2006.02373.X

21 January 2018

Immunogenicity and protective efficacy of a tuberculosis DNA vaccine

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2006.02373.X

21 January 2018

Immunogenicity and protective efficacy of DNA vaccines encoding secreted and non-secreted forms of Mycobacterium tuberculosis Ag85A.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2006.02373.X

21 January 2018

Priming by DNA immunization augments protective efficacy of Mycobacterium bovis Bacille Calmette-Guerin against tuberculosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2006.02373.X

21 January 2018

Boosting vaccine for tuberculosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2006.02373.X

21 January 2018

Improved immunogenicity and protective efficacy of a tuberculosis DNA vaccine encoding Ag85 by protein boosting

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2006.02373.X

21 January 2018

Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Guérin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2006.02373.X

21 January 2018

Evaluation of vaccines in the EU TB Vaccine Cluster using a guinea pig aerosol infection model of tuberculosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2006.02373.X

21 January 2018

Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2006.02373.X

21 January 2018

Mapping of murine Th1 helper T-Cell epitopes of mycolyl transferases Ag85A, Ag85B, and Ag85C from Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2006.02373.X

21 January 2018

Induction of in vivo functional Db-restricted cytolytic T cell activity against a putative phosphate transport receptor of Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2006.02373.X

21 January 2018

Developing an epitope-driven tuberculosis (TB) vaccine

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2006.02373.X

21 January 2018

Differential immune responses and protective efficacy induced by components of a tuberculosis polyprotein vaccine, Mtb72F, delivered as naked DNA or recombinant protein

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2006.02373.X

21 January 2018

Exchanging ESAT6 with TB10.4 in an Ag85B fusion molecule-based tuberculosis subunit vaccine: efficient protection and ESAT6-based sensitive monitoring of vaccine efficacy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2006.02373.X

21 January 2018

Immunology of tuberculosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2006.02373.X

21 January 2018

DNA vaccination for the priming of neutralizing antibodies against non-immunogenic STa enterotoxin from enterotoxigenic Escherichia coli

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2006.02373.X

21 January 2018

Improved tuberculosis DNA vaccines by formulation in cationic lipids

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2006.02373.X

21 January 2018

A lymphokine, provisionally designated interleukin T and produced by a human adult T-cell leukemia line, stimulates T-cell proliferation and the induction of lymphokine-activated killer cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2006.02373.X

21 January 2018

Plasmid DNA vaccination

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2006.02373.X

21 January 2018

Identification of a second Mycobacterium tuberculosis gene cluster encoding proteins of an ABC phosphate transporter

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2006.02373.X

21 January 2018

Genome-wide requirements for Mycobacterium tuberculosis adaptation and survival in macrophages

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2006.02373.X

21 January 2018

CD4+ T cells cross-compete for MHC class II-restricted peptide antigen complexes on the surface of antigen presenting cells.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2006.02373.X

21 January 2018

Members of the 30- to 32-kilodalton mycolyl transferase family (Ag85) from culture filtrate of Mycobacterium avium subsp. paratuberculosis are immunodominant Th1-type antigens recognized early upon infection in mice and cattle

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2006.02373.X

21 January 2018

The use of animal models to guide rational vaccine design

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2006.02373.X

21 January 2018

Immunity to tuberculosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2006.02373.X

21 January 2018

Protective effect of DNA vaccine during chemotherapy on reactivation and reinfection of Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2006.02373.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2006.02373.X

21 January 2018

Evaluation of the immunogenicity of pBudCE4.1 plasmids encoding mycolyl-transferase Ag85A and phosphate transport receptor PstS-3 from Mycobacterium tuberculosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1782306

13 October 2018

Assessment of immunity to mycobacterial infection with luciferase reporter constructs.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1782306

13 October 2018

Differential protective efficacy of DNA vaccines expressing secreted proteins of Mycobacterium tuberculosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1782306

13 October 2018

Vaccination with plasmid DNA encoding mycobacterial antigen 85A stimulates a CD4+ and CD8+ T-cell epitopic repertoire broader than that stimulated by Mycobacterium tuberculosis H37Rv infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1782306

13 October 2018

Three different putative phosphate transport receptors are encoded by the Mycobacterium tuberculosis genome and are present at the surface of Mycobacterium bovis BCG

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1782306

13 October 2018

Influence of genes from the major histocompatibility complex on the antibody repertoire against culture filtrate antigens in mice infected with live Mycobacterium bovis BCG

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1782306

13 October 2018

Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1782306

13 October 2018

Effective vaccination of mice against Mycobacterium tuberculosis infection with a soluble mixture of secreted mycobacterial proteins

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1782306

13 October 2018

The efficacy of bacillus Calmette-Guérin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1782306

13 October 2018

T-cell-epitope mapping of the major secreted mycobacterial antigen Ag85A in tuberculosis and leprosy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1782306

13 October 2018

Mapping of TH1 helper T-cell epitopes on major secreted mycobacterial antigen 85A in mice infected with live Mycobacterium bovis BCG.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1782306

13 October 2018

T cell response to purified filtrate antigen 85 from Mycobacterium bovis Bacilli Calmette-Guérin (BCG) in leprosy patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1782306

13 October 2018

Spleen cell cytokine secretion in Mycobacterium bovis BCG-infected mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1782306

13 October 2018

The antigen 85 complex: a major secretion product of Mycobacterium tuberculosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1782306

13 October 2018

Immunization with extracellular proteins of Mycobacterium tuberculosis induces cell-mediated immune responses and substantial protective immunity in a guinea pig model of pulmonary tuberculosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1782306

13 October 2018

Priming but not boosting with plasmid DNA encoding mycolyl-transferase Ag85A from Mycobacterium tuberculosis increases the survival time of Mycobacterium bovis BCG vaccinated mice against low dose intravenous challenge with M. tuberculosis H37Rv

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2006.02373.X

21 January 2018

Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2006.02373.X

21 January 2018

Immunogenicity and protective efficacy of tuberculosis DNA vaccines encoding putative phosphate transport receptors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1782306

13 October 2018

Protection of macaques against Mycobacterium tuberculosis infection by a subunit vaccine based on a fusion protein of antigen 85B and ESAT-6

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2006.02373.X

21 January 2018

Control of latent Mycobacterium tuberculosis infection is dependent on CD8 T cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2006.02373.X

21 January 2018

CD4+ T cells contain Mycobacterium tuberculosis infection in the absence of CD8+ T cells in mice vaccinated with DNA encoding Ag85A

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2006.02373.X

21 January 2018

DNA vaccines: a review

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2006.02373.X

21 January 2018

A polyvalent DNA vaccine expressing an ESAT6-Ag85B fusion protein protects mice against a primary infection with Mycobacterium tuberculosis and boosts BCG-induced protective immunity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2006.02373.X

21 January 2018

Cutting edge: introduction of an endopeptidase cleavage motif into a determinant flanking region of hen egg lysozyme results in enhanced T cell determinant display

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2006.02373.X

21 January 2018

Specific lymphoproliferation, gamma interferon production, and serum immunoglobulin G directed against a purified 32 kDa mycobacterial protein antigen (P32) in patients with active tuberculosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/16827893

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Control of latent Mycobacterium tuberculosis infection is dependent on CD8 T cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/16827893

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/J.1365-2567.2006.02373.X

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

PMC publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40308913&oldid=1488362290"